Phenotypic and Functional Diversities of Myeloid-Derived Suppressor Cells in Autoimmune Diseases

被引:12
|
作者
Ma, Huijuan [1 ]
Xia, Chang-Qing [2 ]
机构
[1] Jining 1 Peoples Hosp, Dept Nephrol, Jining 272011, Peoples R China
[2] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
基金
中国国家自然科学基金;
关键词
TUMOR PROGRESSION; PERIPHERAL-BLOOD; MOUSE MODEL; MONOCYTES; TOLERANCE; MECHANISM; INDUCE; DIFFERENTIATION; ACCUMULATION; LYMPHOCYTES;
D O I
10.1155/2018/4316584
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Myeloid-derived suppressor cells (MDSCs) are identified as a heterogeneous population of cells with the function to suppress innate as well as adaptive immune responses. The initial studies of MDSCs were primarily focused on the field of animal tumor models or cancer patients. In cancer, MDSCs play the deleterious role to inhibit tumor immunity and to promote tumor development. Over the past few years, an increasing number of studies have investigated the role of MDSCs in autoimmune diseases. The beneficial effects of MDSCs in autoimmunity have been reported by some studies, and thus, immunosuppressive MDSCs may be a novel therapeutic target in autoimmune diseases. There are some controversial findings as well. Many questions such as the activation, differentiation, and suppressive functions of MDSCs and their roles in autoimmune diseases remain unclear. In this review, we have discussed the current understanding of MDSCs in autoimmune diseases.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Myeloid-Derived Suppressor Cells
    Woodland, David L.
    [J]. VIRAL IMMUNOLOGY, 2017, 30 (02) : 81 - 81
  • [22] Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis
    Iacobaeus, Ellen
    Douagi, Iyadh
    Jitschin, Regina
    Marcusson-Stahl, Maritha
    Andren, Anton Toernqvist
    Gavin, Caroline
    Lefsihane, Katia
    Davies, Lindsay C.
    Mougiakakos, Dimitrios
    Kadri, Nadir
    Le Blanc, Katarina
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2018, 96 (08): : 820 - 830
  • [23] THE EXPANSION OF MYELOID-DERIVED SUPPRESSOR CELLS IN PATIENTS WITH RHEUMATIC DISEASES
    Zhu, J.
    Chen, S.
    Wu, L.
    Wang, R.
    Zhao, D.
    Li, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1751 - 1751
  • [24] Immune Surveillance by Myeloid-Derived Suppressor Cells in Liver Diseases
    Sehgal, Rashi
    Kaur, Navkiran
    Ramakrishna, Gayatri
    Trehanpati, Nirupma
    [J]. DIGESTIVE DISEASES, 2022, 40 (03) : 301 - 312
  • [25] The emerging role of myeloid-derived suppressor cells in lung diseases
    Kolahian, Saeed
    Oz, Hasan Halit
    Zhou, Benyuan
    Griessinger, Christoph M.
    Rieber, Nikolaus
    Hartl, Dominik
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (03) : 967 - 977
  • [26] Myeloid-derived Suppressor Cells in Autoimmune Diabetes: Their Antidiabetic Potential and Mechanism
    Yang, Wen-Chin
    [J]. JOURNAL OF DIABETES & METABOLISM, 2013, 4
  • [27] Impact of myeloid-derived suppressor cells on adoptive immunity in autoimmune arthritis
    Liu, Peng
    Crook, Kristen
    Weeks, Michael
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192
  • [28] Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease
    Wegner, Anja
    Verhagen, Johan
    Wraith, David C.
    [J]. IMMUNOLOGY, 2017, 151 (01) : 26 - 42
  • [29] The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis
    Wang, Yungang
    Tian, Jie
    Wang, Shengjun
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 45 (04) : 490 - 495
  • [30] Myeloid-Derived Suppressor Cells in Sepsis
    Schrijver, Irene T.
    Theroude, Charlotte
    Roger, Thierry
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10